| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp. (TNXP) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. TNXP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 39.0K | $475.9K | - | |
| CFO | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| CEO | 20.0K | $244.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2016 | Rhodes John B | Director | Buy | 25,000 | $0.00 | - | +22.3% | |
| Oct 31, 2016 | Mario Ernest | Director | Buy | 100,000 | $0.00 | - | +18.8% | |
| Sep 13, 2016 | Mario Ernest | Director | Buy | 100,000 | $0.79 | $79,180.00 | +23.2% |